p53 mutations in human bladder cancer: Genotypic versus phenotypic patterns

International Journal of Cancer

Volumn 56, Issue 3, 1994, Pages 347-353

  Cordon‐Cardo, Carlos ^a   Dalbagni, Guido ^a   Saez, Guillermo T ^b   Oliva, Maria R ^b   Zhang, Zuo‐Feng ^a   Rosai, Juan ^a   Reuter, Victor E ^a   Pellicer, Angel ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; BLADDER CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; GENE MUTATION; GENOTYPE; HUMAN; HUMAN TISSUE; PHENOTYPE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANTIBODIES, MONOCLONAL; BLADDER NEOPLASMS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 17; COMPARATIVE STUDY; GENES, P53; GENOTYPE; HUMAN; IMMUNOHISTOCHEMISTRY; MUTATION; NEOPLASM STAGING; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTEIN P53; SENSITIVITY AND SPECIFICITY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028179153     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910560309     Document Type: Article

References (30)

1. Monoclonal antibodies against human virus 40 nuclear large‐T‐tumor antigen: epitope mapping, papova virus cross‐reaction and cell surface staining
2. Isolation of human‐p55‐specific monoclonal antibodies and their use in the studies of human p53 expression
3. Biases in the assessment of diagnostic tests
4. Transformation associated p53 protein is encoded by a gene on human chromosome 17
5. Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopatho‐logical indicators of high metastatic potential
6. Degradation of nuclear oncoproteins by the ubiquitin system in vitro
7. Molecular genetic alterations of chromosome 17 and p53 nuclear overexpression in human bladder cancer
8. Presence of a potent transcription activating sequence in the p53 protein
9. Frequent association of p53 gene mutation in invasive bladder cancer
10. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form
11. Stabilization of the p53 transformation‐related protein in mouse fibrosarcoma cell lines: effects of protein sequence and intracellular environment
12. The meaning and use of the area under the receiver operating characteristic curve
13. PCR‐SSCP: a simple and sensitive method for detection of mutations in the genomic DNA
14. Increased expression of mutant forms of p53 oncogene in primary lung cancer
15. Germ Ime p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. TV
16. Two distinct mechanisms alter p53 in breast cancer
17. Treatment of Early‐Stage Breast Cancer
18. Rapid and sensitive deletion of point mutations and DNA polymorphisms using the polymerase chain reaction
19. Molecular genetic alterations in superficial and locally advanced human bladder cancer
20. Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53
21. The lower urinary tract
22. DNA sequencing with chain‐terminating inhibitors
23. Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression
24. Formation of stable p53 homotetramers and multiples of tetramers
25. p53: a frequent target for genetic abnormalities in lung cancer
26. Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer
27. Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas
28. Genetic alterations during colorectal tumor development
29. Type 1 neurofibromatosis gene: Identification of a large transcript disrupted in three NF1 patients